XOMA Royalty Corp. Files 8-K for Corporate Changes
Ticker: XOMAP · Form: 8-K · Filed: Sep 26, 2025 · CIK: 791908
| Field | Detail |
|---|---|
| Company | Xoma Royalty Corp (XOMAP) |
| Form Type | 8-K |
| Filed Date | Sep 26, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0075, $0.05 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
XOMA Royalty Corp. filed an 8-K on 9/23/25 for corporate changes.
AI Summary
On September 23, 2025, XOMA Royalty Corp. filed an 8-K report detailing amendments to its Articles of Incorporation and changes to its fiscal year. The company, formerly known as XOMA Corp, is incorporated in Nevada and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates potential structural or operational adjustments within XOMA Royalty Corp., which could impact its financial reporting and corporate governance.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not appear to involve significant financial transactions or strategic shifts.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
- 001-39801 — SEC File Number (Unique identifier for the company's SEC filings.)
Key Players & Entities
- XOMA Royalty Corp. (company) — Filer
- XOMA Corp (company) — Former company name
- September 23, 2025 (date) — Date of earliest event reported
- 20549 (location) — SEC Washington D.C. ZIP code
- NV (location) — State of incorporation
FAQ
What specific amendments were made to XOMA Royalty Corp.'s Articles of Incorporation?
The filing indicates amendments to Articles of Incorporation but does not specify the exact nature of these amendments in the provided text.
What is the new fiscal year end for XOMA Royalty Corp.?
The filing states the fiscal year end is 1231, which is a standard representation for December 31st, but the filing does not explicitly state a change from a previous year-end.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 23, 2025.
What is XOMA Royalty Corp.'s Standard Industrial Classification (SIC) code?
XOMA Royalty Corp.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of XOMA Royalty Corp.?
The business address of XOMA Royalty Corp. is 2200 Powell Street, Suite 310, Emeryville, CA 94608.
Filing Stats: 573 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-09-26 17:29:26
Key Financial Figures
- $0.0075 — nge on which registered Common Stock, $0.0075 par value XOMA The Nasdaq Global Ma
- $0.05 — ve Perpetual Preferred Stock, par value $0.05 per share XOMAP The Nasdaq Global M
Filing Documents
- d898051d8k.htm (8-K) — 30KB
- d898051dex31.htm (EX-3.1) — 22KB
- g898051new.jpg (GRAPHIC) — 5KB
- g898051sp6b.jpg (GRAPHIC) — 2KB
- g898051sp6c.jpg (GRAPHIC) — 4KB
- 0001193125-25-220830.txt ( ) — 232KB
- xoma-20250923.xsd (EX-101.SCH) — 4KB
- xoma-20250923_def.xml (EX-101.DEF) — 15KB
- xoma-20250923_lab.xml (EX-101.LAB) — 25KB
- xoma-20250923_pre.xml (EX-101.PRE) — 16KB
- d898051d8k_htm.xml (XML) — 8KB
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits. EXHIBIT INDEX Exhibit No. Description 3.1 Certificate of Correction, dated September 23, 2025, to the Certificate of Designation of 8.375% Series B Cumulative Perpetual Preferred Stock. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. XOMA ROYALTY CORPORATION Date: September 26, 2025 By: /s/ Thomas Burns Name: Thomas Burns Title: Senior Vice President, Finance and Chief Financial Officer